TSX futures inch lower after index closes at new all-time high
Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HRGN) CEO He Junli reported purchasing 300 shares of the company’s common stock on September 30, 2025. The shares were bought at a price of $1.98, for a total transaction value of $594. The micro-cap company, currently valued at $32.79 million, has shown strong momentum in recent months according to InvestingPro data. Following the transaction, He Junli directly owns 277,575 shares of Harvard Apparatus Regenerative Technology, Inc. The stock, which typically moves opposite to the broader market with a beta of -0.31, is currently trading below its Fair Value based on comprehensive valuation models. Unlock 8 additional InvestingPro Tips and detailed metrics to make informed investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.